Japanese car software developer Micware (MWC.US) sets IPO pricing at $7-9 per ADS, aiming to raise $30 million.
Micware plans to issue 3.8 million American Depositary Shares (ADS) at a price range of $7 to $9 per share.
Japanese car software developer Micware (MWC.US) submitted an initial public offering (IPO) application to the U.S. Securities and Exchange Commission (SEC) last Friday. According to the disclosure documents, the technology company based in Kobe plans to raise up to $30 million in funds through this U.S. listing. Micware plans to issue 3.8 million American Depositary Shares (ADS) at a price range of $7 to $9 per share.
Established in 2003, Micware has been deeply involved in the field of automotive software for many years, with its core business focusing on the development and integration of In-Vehicle Infotainment (IVI) systems and advanced navigation software. It primarily develops IVI systems for multimedia, navigation, human-machine interaction, remote information processing, and driver assistance functions; as well as navigation software and location-based services for vehicles and smartphones.
As a key software service provider in the Japanese automotive industry, Micware not only provides digital solutions for major OEMs, but has also actively promoted international expansion in recent years. The company has branches in the United States, Germany, and Thailand, aiming to be close to global core automotive markets through multinational operations. The decision to list on the Nasdaq is seen as a key step in enhancing its brand's international recognition and accelerating the development of cutting-edge in-vehicle technologies.
It is understood that the company's revenue mainly comes from software-defined car systems, location-based services, and overseas software development services. It achieved revenue of $139 million in the 12 months ending August 31, 2025, and plans to list on the Nasdaq with the stock code MWC. A.G.P. is serving as the exclusive bookrunner for this offering.
Related Articles

INSILICO (03696) reached global pipeline authorization and AI drug development cooperation with Roche.

CMGE(00302) releases annual performance, with a loss of 1.477 billion yuan, a year-on-year decrease of 30.02%.

JIANGSU EXPRESS (00177) has announced its performance for 2025, with a net profit attributable to shareholders of approximately RMB 4.594 billion, representing a year-on-year decrease of about 7.13%.
INSILICO (03696) reached global pipeline authorization and AI drug development cooperation with Roche.

CMGE(00302) releases annual performance, with a loss of 1.477 billion yuan, a year-on-year decrease of 30.02%.

JIANGSU EXPRESS (00177) has announced its performance for 2025, with a net profit attributable to shareholders of approximately RMB 4.594 billion, representing a year-on-year decrease of about 7.13%.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


